Receptor-type tyrosine-protein phosphatase epsilon Inhibitors (IC50, Ki)

Structure ▲ ▼	Compound Name ▲ ▼	Standard Type ▲ ▼	Standard Values (in nM) ▲ ▼
	Oleanolic acid	IC50	40000.0 [1]
	Ursolic acid	IC50	40000.0 [1]
	Corosolic acid	IC50	40000.0 [1]
	2-(Oxalyl-amino)-benzoic acid	Ki	130000.0 [1]
	2-(Oxalyl-amino)-4,5,6,7-tetrahydro-thieno[2,3-C]pyridine-3-carboxylic acid	Ki	1100000.0 [1]
	(4As,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-(3-carboxy-3-methylbutanoyl)oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid	IC50	40000.0 [1]
	Cefsulodin sodium salt	IC50	200000.0 [1]
	CID 71734765	IC50	25000.0 [1]
	5-Iodo-2-(oxaloamino)benzoic acid	Ki	33000.0 [1]
	6-(Oxalyl-amino)-1H-indole-5-carboxylic acid	Ki	66000.0 [1]
	2-(Oxalyl-amino)-4,7-dihydro-5H-thieno[2,3-C]pyran-3-carboxylic acid	Ki	20000.0 [1]
	2-(Carboxyformamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid	Ki	45000.0 [1]
	1H-Indole-7-carboxylic acid, 6-[(carboxycarbonyl)amino]-	Ki	33000.0 [1]
	2-(Carboxyformamido)thiophene-3-carboxylic acid	Ki	740000.0 [1]
	3-(Carboxyformamido)thiophene-2-carboxylic acid	Ki	360000.0 [1]
	[3-[3-[(3S)-3-(Methylcarbamoyl)-7-(sulfoamino)-3,4-dihydro-1H-isoquinolin-2-yl]-3-oxopropyl]phenyl]sulfamic acid	IC50	500000.0 [1]
	2-(3-Bromoanilino)-5-hydroxybenzothiazole-6-carboxylic acid	IC50	400000.0 [1]
	2-Hydroxy-4-[1-(cyclohexylcarbamoyl)pentyloxy]-5-[2-(trifluoromethoxy)phenylethynyl]benzoic acid	IC50	50000.0 [1]
	2-[4-[[2-(4-Iodoanilino)-2-oxoacetyl]amino]anilino]-2-oxo-1-phenylethanesulfonic acid	IC50	50000.0 [1]
	2-Oxo-2-[4-[[2-oxo-2-(4-phenylanilino)acetyl]amino]anilino]-1-phenylethanesulfonic acid	IC50	50000.0 [1]
	2-Oxo-2-[4-[[2-oxo-2-(4-propan-2-ylanilino)acetyl]amino]anilino]-1-phenylethanesulfonic acid	IC50	50000.0 [1]
	2-(2-Methoxyphenoxy)-N-[(2Z)-5-(phenoxymethyl)-1,3,4-thiadiazol-2(3H)-ylidene]acetamide	IC50	3700.0 [1]
	1-{5-[(2,4-Dimethylphenoxy)methyl]-1,3,4-thiadiazol-2-yl}-3-(4-methylphenyl)urea	IC50	2470.0 [1]
	1-(3-Chloro-4-fluorophenyl)-3-[5-[(2,4-dimethylphenoxy)methyl]-1,3,4-thiadiazol-2-yl]urea	IC50	1860.0 [1]
	1-(5-{[4-(Butan-2-yl)phenoxy]methyl}-1,3,4-thiadiazol-2-yl)-3-(2-methoxyphenyl)urea	IC50	4170.0 [1]
	N-[(3beta)-3-Hydroxy-28-oxoolean-12-en-28-yl]-L-phenylalanine	IC50	40000.0 [1]
	3-[(4Ar,6aR,6aS,6bR,8aR,10S,12aR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicen-4a-yl]propanoic acid	IC50	40000.0 [1]
	5-[(4Ar,6aR,6aS,6bR,8aR,10S,12aR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicen-4a-yl]pentanoic acid	IC50	40000.0 [1]
	(2S)-2-[5-[(4Ar,6aR,6aS,6bR,8aR,10S,12aR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicen-4a-yl]pentanoylamino]-3-phenylpropanoic acid	IC50	40000.0 [1]
	2-[5-[(4Ar,6aR,6aS,6bR,8aR,10S,12aR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicen-4a-yl]pentanoylamino]-3-(1,3-benzodioxol-5-yl)propanoic acid	IC50	40000.0 [1]
	(4As,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-[(4-carboxyphenyl)methoxy]-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid	IC50	40000.0 [1]
	4-[[(3S,4Ar,6aR,6bS,8aR,12aR,14aR,14bR)-8a-[5-[[(1S)-1-carboxy-2-phenylethyl]amino]-5-oxopentyl]-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxymethyl]benzoic acid	IC50	40000.0 [1]
	(7S)-7-[(1,1-Dioxo-1,2-benzothiazol-3-yl)oxymethyl]-2-(oxaloamino)-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxylic acid	Ki	500000.0 [1]
	2-(3-(Dihydroxymethyl)naphthalen-2-ylamino)-2-oxoacetic acid	Ki	45000.0 [1]
	Azane;[4-[4-ethoxy-2,2-bis(methoxycarbonyl)-4-oxobutyl]phenyl]sulfamic acid	IC50	500000.0 [1]
	Azane;[4-[2,2-bis(methoxycarbonyl)-5-phenylpentyl]phenyl]sulfamic acid	IC50	500000.0 [1]
	Azane;[4-[2-ethoxycarbonyl-3-methoxy-3-oxo-2-(phenylmethoxycarbonylamino)propyl]phenyl]sulfamic acid	IC50	500000.0 [1]
	2-(1,3-Benzodioxol-5-yloxy)-N-{5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl}acetamide	IC50	2010.0 [1]
	Lyp-IN-1	IC50	25000.0 [1]
	6-Hydroxy-3-iodo-1-methyl-2-[3-[[2-oxo-2-(4-thiophen-3-ylanilino)acetyl]amino]phenyl]indole-5-carboxylic acid	IC50	20000.0 [1]

Entire TableStructureCompound NameStandard TypeStandard Values (in nM)

Items per page: 510All1 - 10 of 40 ⟨⟩

---

---

References

This online tool may be cited as follows

MLA	"Quest Database™ Receptor-type tyrosine-protein phosphatase epsilon Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 20 Feb. 2025, https://www.aatbio.com/data-sets/receptor-type-tyrosine-protein-phosphatase-epsilon-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, February 20). Quest Database™ Receptor-type tyrosine-protein phosphatase epsilon Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/receptor-type-tyrosine-protein-phosphatase-epsilon-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan